Furthermore, immature DCs prepared from peripheral blood MNCs from breast cancer patients expressed high levels of CD11c (79 ± 14% CD11c+Lin-), but large individual differences in HLA-DR expression were recorded. The gene discussed is ITGAX; the disease is breast carcinoma.